Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asahi Intecc CoFRA:6XT -2.67%97 Peter Lynch Fair Value is €7.52 as of Jul. 23, 2026, which is 100% below its 10-year median of 2.90. GuruFocus rates FRA:6XT with a GF Score™ of 97/100 and a GF Value™ of €17.19 (Fairly Valued). The stock has 3 warning signs investors should review. Among 153 Medical Devices & Instruments companies, Asahi Intecc Co ranks worse than 56.86% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Asahi Intecc Co's PEG is 1. Asahi Intecc Co's 5-Year TTM EBITDA Growth Rate is 13.78.
Asahi Intecc Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.55. Therefore, the Peter Lynch Fair Value for today is €7.52.
As of today (2026-07-23), Asahi Intecc Co's share price is €18.20. Asahi Intecc Co's Peter Lynch fair value is €7.52. Therefore, Asahi Intecc Co's Price to Peter Lynch Fair Value Ratio for today is 2.42.
The historical rank and industry rank for Asahi Intecc Co's Peter Lynch Fair Value or its related term are showing as below:
FRA:6XT'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.35 Med: 2.9 Max: 20.26
Current: 1.65
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Asahi Intecc Co was 20.26. The lowest was 1.35. And the median was 2.90.
FRA:6XT's Price-to-Peter-Lynch-Fair-Value is ranked worse than 56.86% of 153
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs FRA:6XT: 1.65
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Asahi Intecc Co (FRA:6XT) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 13.78 instead of 15 in this case.
Asahi Intecc Co's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
18.20
/
7.52
=
2.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asahi Intecc Co Peter Lynch Fair Value Related Terms
Asahi Intecc Co Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for Asahi Intecc Co's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:6XT vs ISRG, BDX, MDLN: Peter Lynch Fair Value Comparison
For the Medical Instruments & Supplies subindustry, Asahi Intecc Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asahi Intecc Co Price-to-Peter-Lynch-Fair-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Asahi Intecc Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Asahi Intecc Co's Price-to-Peter-Lynch-Fair-Value falls into.
Asahi Intecc Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.55.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
Asahi Intecc Co (FRA:6XT) has a Peter Lynch Fair Value of €7.52 as of Jul. 23, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Asahi Intecc Co and its competitors. This is 159% above median its historical median of 2.90. Over the past decade, Asahi Intecc Co's Peter Lynch Fair Value has ranged from 1.35 to 20.26. According to the industry distribution chart, Asahi Intecc Co ranks #87 out of 153 companies in the Medical Devices & Instruments industry, placing it in the top 56.9%.
Is Asahi Intecc Co's Peter Lynch Fair Value too high?
Asahi Intecc Co's current Peter Lynch Fair Value of €7.52 is 159% above median its 10-year median of 2.90. Over the past 10 years, this metric has ranged from a low of 1.35 to a high of 20.26. Based on the distribution chart, Asahi Intecc Co ranks #87 out of 153 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Asahi Intecc Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Asahi Intecc Co's Peter Lynch Fair Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Asahi Intecc Co ranks #87 out of 153 companies for Peter Lynch Fair Value. This places Asahi Intecc Co in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.47. Historically, Asahi Intecc Co's own Peter Lynch Fair Value has ranged from 1.35 to 20.26 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Medical Devices & Instruments company?
The median Peter Lynch Fair Value among Medical Devices & Instruments companies is 1.47, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Asahi Intecc Co and its competitors. For the Medical Devices & Instruments industry, the median Peter Lynch Fair Value is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asahi Intecc Co's current Peter Lynch Fair Value is €7.52, which is 159% above median its own 10-year median of 2.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asahi Intecc Co stock overvalued right now?
Based on GuruFocus' analysis, Asahi Intecc Co (FRA:6XT) is currently considered Fairly Valued. The stock's GF Value™ is €17.19, compared to a current price of €18.20 — trading 5.9% above its estimated fair value. The current Peter Lynch Fair Value is €7.52, which is 159% above median its 10-year median of 2.90. Asahi Intecc Co's overall GF Score™ is 97/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Asahi Intecc Co (FRA:6XT), the current Peter Lynch Fair Value is €7.52 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asahi Intecc Co (FRA:6XT) Overvalued in 2026?
Based on GuruFocus' analysis, Asahi Intecc Co stock appears to be overvalued.
The current stock price of €18.20 is trading 5.9% above its estimated GF Value™ of €17.19.
GuruFocus considers Asahi Intecc Co to be Fairly Valued.
Key valuation signals for FRA:6XT:
Peter Lynch Fair Value: €7.52 (159% above median its 10-year median of 2.90)
GF Value™: €17.19 vs. price of €18.20 (5.9% above fair value)
No single metric tells the full story. See the FRA:6XT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asahi Intecc Co Ltd is engaged in the development, manufacturing, and sales of medical and industrial equipment components. The company operates through two reportable segments: Medical Business and Device Business. The Medical Business develops, manufactures, and sells proprietary and OEM products in the medical equipment field, while the Device Business focuses on components for medical and industrial equipment applications. It generates the majority of its revenue from the Medical Business segment.
97GF Score
Get the complete analysis for FRA:6XT
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6XT has been successfully added to your 
